Bristol-Myers Squibb Financial Statements
Bristol-Myers Squibb Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Bristol-Myers Squibb Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 20,597.0 | 19,348.0 | 17,914.0 |
| Gross Profit ($ mil.) | 14,201.0 | 13,130.0 | 11,958.0 |
| Operating Income ($ mil.) | 5,781.0 | 3,956.0 | 3,133.0 |
| Total Net Income ($ mil.) | 5,247.0 | 2,165.0 | 1,585.0 |
| Diluted EPS (Net Income) | 2.63 | 1.09 | 0.81 |
Bristol-Myers Squibb Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 5,487.0 | 5,384.0 | 5,384.0 |
| Gross Profit ($ mil.) | 3,925.0 | 3,923.0 | 3,923.0 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | 1,290.0 | 1,298.0 | 1,298.0 |
| Diluted EPS (Net Income) | 0.48 | 0.49 | 0.49 |
Bristol-Myers Squibb Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.11 | 2.65 | 7.00 |
| Price/Earnings Ratio | 11.22 | 16.81 | 25.45 |
| Price/Book Ratio | 3.07 | 2.88 | 6.74 |
| Price/Cash Flow Ratio | 14.33 | 10.14 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Bristol-Myers Squibb Financial Ratios
Bristol-Myers Squibb Competitive Intelligence
| Merck | Novartis | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,502.0 | 42,584.0 | 48,296.0 |
| Employees | 51,000 | 96,717 | 81,800 |
| Market Cap ($ mil.) | 46,142.1 | 119,419.7 | 114,870.4 |
Competitive Landscape
